Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond is a research paper published in Pharmaceutical Research (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: R21TR001718
National Institute of General Medical Sciences
Grant: R44GM122196-02A1
NIGMS NIH HHS
Grant: R44 GM122196
National Institutes of Health
Grant: 2R44GM122196-04A1
Centralized assay datasets for modelling support of small drug discovery organizations
National Institutes of Health
Grant: 1R21TR001718-01
Repurposing pyronaridine as a treatment for the Ebola virus
FWCI
3.01
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 3 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 3 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 1 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 2 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 1 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 2 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model